
Overview
Background
Professor István Tóth is Chair in Biological Chemistry at The University of Queensland (UQ), Brisbane, Australia, and Affiliated Professorial Research Fellow at the Institute of Molecular Biosciences, UQ. He graduated with a degree in Chemical Engineering from the Technical University, Budapest, Hungary and was awarded his PhD for his Alkaloid Chemistry research. Professor Tóth undertook a postdoctoral fellowship at Carleton University, Ottawa Canada before returning to Hungary to work as a Research Associate, then Scientific Group Leader at the Central Research Institute for Chemistry, Hungarian Academy of Science. He joined the School of Pharmacy at the University of London in 1987 as a Senior Lecturer and Royal Society sponsored Senior Research Fellow. He became a Reader in Medicinal Organic Chemistry in 1994 and was awarded a Doctor of Science degree (DSc 1994) for his work in Drug Delivery (Hungarian Academy of Sciences), before relocating to the University of Queensland in 1998 where he has built a productive research group. Professor Tóth was a visiting professor at the School of Pharmacy, University of London (1994-2004) and at the Department of Bioengineering and Therapeutic Science, University of California, San Francisco (2011-2013). Professor Tóth’s major research interests are: drug delivery, immunoadjuvants, carbohydrates, lipids, peptides, nucleosides, and nucleotides. This research has attracted over $85 million in competitive grants, research contracts and investment funds in the past 10 years. Professor Tóth has over 500 peer-reviewed publications, 45 patents, and an excellent track record in research commercialisation. He is a one of key founders of Alchemia, Implicit Bioscience Pty Ltd, Neurotide Pty Ltd and TetraQ (the commercial arm of Centre of Integrated Preclinical Drug Development). Professor Tóth is an elected RACI Fellow and Fellow of the Queensland Academy of Arts and Sciences. and Feklloiw of the Hungarian Academy of Sciences (since 2016) In 2009 he was awarded the Adrian Albert award for sustained and outstanding research in medicinal biochemistry, and a Business/Higher Education Round Table (BHERT) Award for Outstanding Achievement in International Collaborative Research and Development he obtained the Doctor Honoris Causa degree at Semmelweis university budapest Hungary (2019). Professor Tóth was appointed as a member of the ARC College of Experts (2008-2010). He was the founding (2007) then the elected (2008-2009) President of the Australian Chapter of Controlled Release Society.
Availability
- Emeritus Professor Istvan Toth is:
- Not available for supervision
- Media expert
Fields of research
Qualifications
- Doctor of Philosophy of Medicinal and Biomolecular Chemistry, Budapest University of Technology and Economics
- Doctoral Diploma of Medicinal and Biomolecular Chemistry, Budapest University of Technology and Economics
Works
Search Professor Istvan Toth’s works on UQ eSpace
2021
Journal Article
Cyclic dipeptides: the biological and structural landscape with special focus on the anti-cancer proline-based scaffold
Bojarska, Joanna, Mieczkowski, Adam, Ziora, Zyta, Skwarczynski, Mariusz, Toth, Istvan, Shalash, Ahmed O., Parang, Keykavous, El-Mowafi, Shaima A., Mohammed, Eman H. M., Elnagdy, Sherif, AlKhazindar, Maha and Wolf, Wojciech M. (2021). Cyclic dipeptides: the biological and structural landscape with special focus on the anti-cancer proline-based scaffold. Biomolecules, 11 (10) 1515, 1515. doi: 10.3390/biom11101515
2021
Journal Article
Oral peptide vaccine against hookworm infection: correlation of antibody titers with protective efficacy
Shalash, Ahmed O., Becker, Luke, Yang, Jieru, Giacomin, Paul, Pearson, Mark, Hussein, Waleed M., Loukas, Alex, Skwarczynski, Mariusz and Toth, Istvan (2021). Oral peptide vaccine against hookworm infection: correlation of antibody titers with protective efficacy. Vaccines, 9 (9) 1034, 1034. doi: 10.3390/vaccines9091034
2021
Journal Article
Poly(hydrophobic amino acid) conjugates for the delivery of multiepitope vaccine against Group A Streptococcus
Azuar, Armira, Shibu, Mohini A., Adilbish, Nomin, Marasini, Nirmal, Hung, Hong, Yang, Jieru, Luo, Yacheng, Khalil, Zeinab G., Capon, Robert J., Hussein, Waleed M., Toth, Istvan and Skwarczynski, Mariusz (2021). Poly(hydrophobic amino acid) conjugates for the delivery of multiepitope vaccine against Group A Streptococcus. Bioconjugate Chemistry, 32 (11) acs.bioconjchem.1c00333, 2307-2317. doi: 10.1021/acs.bioconjchem.1c00333
2021
Journal Article
Polyacrylate-GnRH peptide conjugate as an oral contraceptive vaccine candidate
Faruck, Mohammad O., Koirala, Prashamsa, Yang, Jieru, D’Occhio, Michael J., Skwarczynski, Mariusz and Toth, Istvan (2021). Polyacrylate-GnRH peptide conjugate as an oral contraceptive vaccine candidate. Pharmaceutics, 13 (7) 1081, 1-15. doi: 10.3390/pharmaceutics13071081
2021
Other Outputs
Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay
Shalash, Ahmed O., Azuar, Armira, Madge, Harrison Y. R., Modhiran, Naphak, Amarilla, Alberto A., Liang, Benjamin, Khromykh, Alexander, Watterson, Daniel, Young, Paul R., Toth, Istvan and Skwarczynski, Mariusz (2021). Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay. doi: 10.21203/rs.3.pex-1559/v1
2021
Journal Article
Key considerations for the development of safe and effective SARS‐CoV‐2 subunit vaccine: a peptide‐based vaccine alternative
Shalash, Ahmed O., Hussein, Waleed M., Skwarczynski, Mariusz and Toth, Istvan (2021). Key considerations for the development of safe and effective SARS‐CoV‐2 subunit vaccine: a peptide‐based vaccine alternative. Advanced Science, 8 (16) 2100985, 1-35. doi: 10.1002/advs.202100985
2021
Journal Article
Pre-clinical evaluation of a whole-parasite vaccine to control human babesiosis
Al-Nazal, Hanan A., Cooper, Emily, Ho, Mei Fong, Eskandari, Sharareh, Majam, Victoria, Giddam, Ashwini Kumar, Hussein, Waleed M., Islam, Md Tanjir, Skwarczynski, Mariusz, Toth, Istvan, Kumar, Sanjai, Zaid, Ali, Batzloff, Michael, Stanisic, Danielle I. and Good, Michael F. (2021). Pre-clinical evaluation of a whole-parasite vaccine to control human babesiosis. Cell Host and Microbe, 29 (6), 894-903. doi: 10.1016/j.chom.2021.04.008
2021
Journal Article
Chemical conjugation strategies for the development of protein-based subunit nanovaccines
Lu, Lantian, Duong, Viet Tram, Shalash, Ahmed O., Skwarczynski, Mariusz and Toth, Istvan (2021). Chemical conjugation strategies for the development of protein-based subunit nanovaccines. Vaccines, 9 (6) 563, 1-24. doi: 10.3390/vaccines9060563
2021
Journal Article
Polyethylenimine quantity and molecular weight influence its adjuvanting properties in liposomal peptide vaccines
Dai, Charles C., Huang, Wenbin, Yang, Jieru, Hussein, Waleed M., Wang, Jingwen, Khalil, Zeinab G., Capon, Robert J., Toth, Istvan and Stephenson, Rachel J. (2021). Polyethylenimine quantity and molecular weight influence its adjuvanting properties in liposomal peptide vaccines. Bioorganic and Medicinal Chemistry Letters, 40 127920, 1-7. doi: 10.1016/j.bmcl.2021.127920
2021
Journal Article
Cell-penetrating peptides-based liposomal delivery system enhanced immunogenicity of peptide-based vaccine against group A streptococcus
Yang, Jieru, Firdaus, Farrhana, Azuar, Armira, Khalil, Zeinab G., Marasini, Nirmal, Capon, Robert J., Hussein, Waleed M., Toth, Istvan and Skwarczynski, Mariusz (2021). Cell-penetrating peptides-based liposomal delivery system enhanced immunogenicity of peptide-based vaccine against group A streptococcus. Vaccines, 9 (5) 499, 499. doi: 10.3390/vaccines9050499
2021
Journal Article
Immunogenicity assessment of cell wall carbohydrates of Group A Streptococcus via self-adjuvanted glyco-lipopeptides
Khatun, Farjana, Dai, Charles C., Rivera-Hernandez, Tania, Hussein, Waleed M., Khalil, Zeinab G., Capon, Robert J., Toth, Istvan and Stephenson, Rachel J. (2021). Immunogenicity assessment of cell wall carbohydrates of Group A Streptococcus via self-adjuvanted glyco-lipopeptides. ACS Infectious Diseases, 7 (2) acsinfecdis.0c00722, 390-405. doi: 10.1021/acsinfecdis.0c00722
2021
Journal Article
Poly(hydrophobic amino acid)-based self-adjuvanting nanoparticles for Group A Streptococcus vaccine delivery
Azuar, Armira, Li, Zhuoqing, Shibu, Mohini A., Zhao, Lili, Luo, Yacheng, Shalash, Ahmed O., Khalil, Zeinab G., Capon, Robert J., Hussein, Waleed M., Toth, Istvan and Skwarczynski, Mariusz (2021). Poly(hydrophobic amino acid)-based self-adjuvanting nanoparticles for Group A Streptococcus vaccine delivery. Journal of Medicinal Chemistry, 64 (5) acs.jmedchem.0c01660, 2648-2658. doi: 10.1021/acs.jmedchem.0c01660
2021
Journal Article
A global review on short peptides: frontiers and perspectives
Apostolopoulos, Vasso, Bojarska, Joanna, Chai, Tsun-Thai, Elnagdy, Sherif, Kaczmarek, Krzysztof, Matsoukas, John, New, Roger, Parang, Keykavous, Lopez, Octavio Paredes, Parhiz, Hamideh, Perera, Conrad O., Pickholz, Monica, Remko, Milan, Saviano, Michele, Skwarczynski, Mariusz, Tang, Yefeng, Wolf, Wojciech M., Yoshiya, Taku, Zabrocki, Janusz, Zielenkiewicz, Piotr, AlKhazindar, Maha, Barriga, Vanessa, Kelaidonis, Konstantinos, Sarasia, Elham Mousavinezhad and Toth, Istvan (2021). A global review on short peptides: frontiers and perspectives. Molecules, 26 (2) 430, 430. doi: 10.3390/molecules26020430
2021
Book Chapter
Peptide-pegylated lipid conjugation via copper-catalyzed alkyne-azide 1,3-dipolar cycloaddition
Hussein, Waleed M. and Toth, Istvan (2021). Peptide-pegylated lipid conjugation via copper-catalyzed alkyne-azide 1,3-dipolar cycloaddition. Peptide conjugation: methods and protocols. (pp. 57-64) New York, NY United States: Humana Press. doi: 10.1007/978-1-0716-1617-8_6
2021
Journal Article
A potent vaccine delivery system
Zhao, Guangzu, Azuar, Armira, Toth, Istvan and Skwarczynski, Mariusz (2021). A potent vaccine delivery system. Bio-protocol, 11 (7) e3973, e3973. doi: 10.21769/bioprotoc.3973
2021
Journal Article
Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2
Pandey, Manisha, Ozberk, Victoria, Eskandari, Sharareh, Shalash, Ahmed O., Joyce, Michael A., Saffran, Holly A., Day, Christopher J., Lepletier, Ailin, Spillings, Belinda L., Mills, Jamie-Lee, Calcutt, Ainslie, Fan, Fan, Williams, James T., Stanisic, Danielle I., Hattingh, Laetitia, Gerrard, John, Skwarczynski, Mariusz, Mak, Johnson, Jennings, Michael P., Toth, Istvan, Tyrrell, D. Lorne and Good, Michael F. (2021). Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2. Clinical and Translational Immunology, 10 (3) e1260, e1260. doi: 10.1002/cti2.1260
2021
Book Chapter
Peptide-Polymer Conjugation Via Copper-Catalyzed Alkyne-Azide 1,3-Dipolar Cycloaddition
Hussein, Waleed M., Toth, Istvan and Skwarczynski, Mariusz (2021). Peptide-Polymer Conjugation Via Copper-Catalyzed Alkyne-Azide 1,3-Dipolar Cycloaddition. Methods in Molecular Biology. (pp. 1-7) New York, NY United States: Humana Press. doi: 10.1007/978-1-0716-1617-8_1
2021
Book
Peptide Conjugation : Methods and Protocols
Hussein, Waleed M., Stephenson, Rachel J. and Toth, Istvan eds. (2021). Peptide Conjugation : Methods and Protocols. Methods in Molecular Biology, New York, NY United States: Springer. doi: 10.1007/978-1-0716-1617-8
2021
Book Chapter
Double conjugation using mercapto-acryloyl and alkyne-azide reactions for the synthesis of branched multiantigenic vaccine candidates
Hussein, Waleed M., Skwarczynski, Mariusz and Toth, Istvan (2021). Double conjugation using mercapto-acryloyl and alkyne-azide reactions for the synthesis of branched multiantigenic vaccine candidates. Peptide conjugation: methods and protocols. (pp. 141-150) New York, NY United States: Humana Press. doi: 10.1007/978-1-0716-1617-8_13
2021
Book Chapter
Nanocarrier-based vaccine delivery systems for synthetic peptide vaccines
Madge, Harrison Y.R., Stephenson, Rachel J. and Toth, Istvan (2021). Nanocarrier-based vaccine delivery systems for synthetic peptide vaccines. Handbook of nanotechnology applications: environment, energy, agriculture and medicine. (pp. 509-535) edited by Woei Jye Lau, Kajornsak Faungnawakij, Kuakoon Piyachomkwan and Uracha Rungsardthong Ruktanonchai. Amsterdam, Netherlands: Elsevier. doi: 10.1016/b978-0-12-821506-7.00020-x
Supervision
Availability
- Emeritus Professor Istvan Toth is:
- Not available for supervision
Supervision history
Current supervision
-
Doctor Philosophy
A nanovaccine against Invasive Group A Streptococcus and Rheumatic Heart Disease
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski, Dr Rachel Stephenson
-
Doctor Philosophy
Development of a peptide-based delivery platform for targeted gene editing
Associate Advisor
Other advisors: Dr Anjuman Begum, Associate Professor Peter Moyle
-
Doctor Philosophy
Poly(hydrophobic amino acids) as immune stimulators.
Associate Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
Doctor Philosophy
Poly(hydrophobic amino acids) as immune stimulators.
Associate Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
Doctor Philosophy
Novel Vaccine Designs of Adjuvants and Delivery Systems against Infectious Diseases
Associate Advisor
Other advisors: Associate Professor Mariusz Skwarczynski, Dr Rachel Stephenson
-
Doctor Philosophy
L-Rhamnose-based nanovaccine derived from poly-rhamnose backbone of Group A Carbohydrate (GAC) against Invasive Group A Streptococcus and Rheumatic Heart Disease
Associate Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
Doctor Philosophy
Polymers and peptides for vaccine delivery.
Associate Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
Doctor Philosophy
Poly(hydrophobic amino acids) as immune stimulators.
Associate Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
Doctor Philosophy
Nanovaccines against infectious diseases
Associate Advisor
Other advisors: Dr Rachel Stephenson
-
Doctor Philosophy
Hookworm vaccine: vaccine development toward clinical trials
Associate Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
Completed supervision
-
2025
Doctor Philosophy
Development of poly(hydrophobic amino acids)-based immunopotentiators for subunit vaccines against infectious diseases
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski, Dr Jazmina Gonzalez Cruz
-
2023
Doctor Philosophy
Polymers as a nanoparticulate adjuvant and vaccine delivery system
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2023
Doctor Philosophy
The role of shape in vaccine delivery: Polymeric nanoparticles-based peptide vaccine against Group A Streptococci (GAS) infection
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2023
Doctor Philosophy
Lipophilic Peptides as Immune Stimulants
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2023
Doctor Philosophy
Cholesterol-based Vaccine Delivery Systems against Group A Streptococcal Infection
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2023
Doctor Philosophy
Development of Peptide-based Vaccines against Infectious Diseases: Hookworm, Liver fluke, and SARS-CoV-2 virus
Principal Advisor
Other advisors: Dr Waleed Hussein, Associate Professor Mariusz Skwarczynski
-
2022
Doctor Philosophy
Targeting lectin receptors for vaccine delivery against group A streptococcus
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2022
Doctor Philosophy
Development of polyacrylate-based delivery systems for peptide vaccines
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2022
Doctor Philosophy
Development of an effective prophylactic and therapeutic treatment for malaria
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2021
Doctor Philosophy
Novel Nanovaccines against Rheumatic Heart Disease
Principal Advisor
Other advisors: Dr Rachel Stephenson
-
2020
Doctor Philosophy
Hydrophobic amino acid-based vaccine delivery systems to induce cellular and humoral immunity
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2020
Doctor Philosophy
Design and evaluation of polysaccharide-based nanoparticles for mucosal vaccine delivery
Principal Advisor
Other advisors: Dr Waleed Hussein, Associate Professor Mariusz Skwarczynski
-
2019
Doctor Philosophy
Optimizing nuclear localization of non-viral DNA delivery vectors
Principal Advisor
Other advisors: Associate Professor Peter Moyle, Dr Waleed Hussein
-
2019
Doctor Philosophy
Development of novel nanoparticulate polymeric delivery system for peptide vaccines against group A streptococcus
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2018
Doctor Philosophy
Peptide-Based Self-Assembling Delivery System for Development of Group A Streptococcus Vaccine
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2018
Doctor Philosophy
Development of Glyco-lipopeptide Vaccines against Group A Streptococcus
Principal Advisor
Other advisors: Dr Rachel Stephenson
-
2018
Doctor Philosophy
Development of peptide-based multicomponent systems for the targeted delivery of oligonucleotides
Principal Advisor
Other advisors: Associate Professor Peter Moyle
-
2017
Doctor Philosophy
Development of peptide-based multicomponent delivery system for oligonucleotides
Principal Advisor
Other advisors: Associate Professor Peter Moyle
-
2017
Doctor Philosophy
Development of a Peptide-Based Multicomponent Oligonucleotide Delivery System
Principal Advisor
Other advisors: Associate Professor Peter Moyle, Dr Waleed Hussein
-
2017
Doctor Philosophy
Development of novel nanoparticle-based mucosal delivery systems for lipopeptide vaccine against group A streptococcus
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2016
Doctor Philosophy
Liposome-based delivery system for the development of malaria vaccine
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2016
Doctor Philosophy
Development of Peptide-Based Vaccines Against Group A Streptococcus (GAS) and Malaria
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2016
Doctor Philosophy
Therapeutic and Preventive Potential of Synthetic Lipopeptides against Bacterial Infections
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2016
Doctor Philosophy
Development of Novel Strategies for Delivery of Vaccine Candidates Against Group A Streptococcus
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski, Dr Waleed Hussein
-
2016
Doctor Philosophy
Synthesis and physicochemical examination of asymmetric amphoteric macromolecules containing OVA CD4 and OVA CD8 for the development of a model vaccine
Principal Advisor
Other advisors: Dr Rachel Stephenson
-
2016
Doctor Philosophy
Mannosylated lipopetides as model vaccines for targeting the mannose receptor
Principal Advisor
Other advisors: Dr Rachel Stephenson
-
2015
Doctor Philosophy
Design, synthesis, and evaluation of anti-LHRH vaccine candidates based on a lipopeptide delivery system
Principal Advisor
-
2015
Doctor Philosophy
Improving the Bioavailability and Stability of Luteinizing Hormone-Releasing Hormone (LHRH) Analogues
Principal Advisor
-
2015
Doctor Philosophy
Self-assembling and self-adjuvanting polymer-peptide conjugates as therapeutic vaccines against cervical cancer
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2015
Doctor Philosophy
The Development of Peptide-Based Subunit Vaccines against Streptococcus pyogenes, Necator americanus and Schistosome mansoni.
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2014
Doctor Philosophy
Lipid and carbohydrate-based systems to enhance the bioavailability and immunogenicity of therapeutic peptides
Principal Advisor
-
2012
Doctor Philosophy
Towards the Development of a Mucosally Active Vaccine against Group A Streptococcus (GAS)
Principal Advisor
-
2012
Doctor Philosophy
Synthesis and Pharmacological Characterization of Endomorphin-1 Analogues
Principal Advisor
Other advisors: Professor Joanne Blanchfield
-
2011
Doctor Philosophy
The Synthesis, Physicochemical Characterization and Biological Interactions of Polymer-coated Nanoparticles
Principal Advisor
Other advisors: Professor Michael Monteiro
-
2011
Doctor Philosophy
Synthesis and Evaluation of Influenza Virosome Gene Delivery and LCP-Based Hookworm Vaccine Delivery Systems
Principal Advisor
-
-
2010
Doctor Philosophy
Lipopeptide-Carbohydrate-Antigen Platforms for Synthetic Vaccine Development
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2010
Doctor Philosophy
The synthesis and characterization of peptide-based carriers for gene delivery and peptide therapeutics
Principal Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2009
Doctor Philosophy
Towards fully synthetic intranasal peptide-based vaccine against group A streptococcal infections
Principal Advisor
-
2008
Doctor Philosophy
Nanoparticulate Carriers And Adjuvants For Novel Synthetic Peptide Vaccines
Principal Advisor
Other advisors: Professor Michael Monteiro
-
2006
Doctor Philosophy
VACCINE-ADJUVANT-CARRIER DESIGN AGAINST GROUP A STREPTOCOCCUSI AND HUMAN PAPILLOMAVIRUS TYPE-16 INFECTION
Principal Advisor
Other advisors: Professor Joanne Blanchfield
-
2005
Doctor Philosophy
PEPTIDE ABSORPTION ENHANCEMENT USING GLYCOLIPID CHEMICAL CONJUGATION
Principal Advisor
-
2004
Doctor Philosophy
LIPOAMINO ACID- AND CARBOHYDRATE-BASED PENETRATION ENHANCERS FOR USE IN ORAL DRUG DELIVERY
Principal Advisor
Other advisors: Professor Joanne Blanchfield
-
2025
Doctor Philosophy
Optimising gene delivery platforms for future in vivo applications
Associate Advisor
Other advisors: Dr Anjuman Begum, Associate Professor Peter Moyle
-
2024
Doctor Philosophy
Design and Synthesis of Self-adjuvant, Pathogen Selective Group A Streptococcus Vaccines
Associate Advisor
Other advisors: Dr Rachel Stephenson
-
2022
Doctor Philosophy
Development of Vaccine Delivery Systems for Peptide Antigens and Small Molecule Haptens
Associate Advisor
Other advisors: Dr Rachel Stephenson
-
2022
Doctor Philosophy
Development of a blood stage DNA vaccine against Plasmodium falciparum
Associate Advisor
Other advisors: Associate Professor Peter Moyle
-
2022
Doctor Philosophy
Development of a new peptide-based self-adjuvanting delivery system for vaccine against Group A Streptococcus (GAS)
Associate Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2022
Doctor Philosophy
Delivery of a peptide-based vaccine against group A streptococcus with the help of cell-penetrating peptides
Associate Advisor
Other advisors: Associate Professor Mariusz Skwarczynski
-
2018
Doctor Philosophy
Epitope-focused vaccines against respiratory syncytial virus
Associate Advisor
Other advisors: Professor Keith Chappell, Professor Daniel Watterson, Associate Professor Mariusz Skwarczynski
-
-
2011
Doctor Philosophy
The Interaction of Synthetic Nanoparticles with Biological Systems
Associate Advisor
Other advisors: Professor Darren Martin
-
-
2009
Doctor Philosophy
Targeting central nervous system active peptides to the brain via nasal delivery
Associate Advisor
Other advisors: Professor Joanne Blanchfield
-
2008
Doctor Philosophy
The efficacy of bile pigment supplementation: In vitro and in vivo considerations
Associate Advisor
Other advisors: Professor Jeff Coombes, Professor Joanne Blanchfield
-
2007
Doctor Philosophy
A NOVEL LIPOSACCHARIDE SYSTEM FOR THE DELIVERY OF ENDOMORPHIN1 ACROSS THE BLOOD-BRAIN BARRIER
Associate Advisor
Other advisors: Professor Joanne Blanchfield
Media
Enquiries
Contact Emeritus Professor Istvan Toth directly for media enquiries about:
- Chemistry - lipid
- Chemistry - medicinal
- Chemistry - peptide
- Chemistry - sugar
- Drug - oral administration
- Drug delivery
- Genes and vaccines
- Immunisation
- Lipid chemistry
- Medicinal chemistry
- Oral administration of vaccines
- Peptide chemistry
- Peptide drug delivery
- Sugar chemistry
- Vaccines - oral administration
- Vaccines and genes
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: